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Necessity  for  Excellent  Glycemic  Control  Before,  During  and  After   CABG  Surgery 
Sheri Clouse, RN, CDE, Diabetic Education Coordinator at Marion General Hospital 
Case Study Conclusion 
     Hyperglycemia during CABG and cardiac procedures 
increases the  likelihood of complications caused by 
increased release of free fatty acids, inflammation and 
oxidative vascular stress.  Poor neutrophil phagocytic 
function and decreased collagen production in the sternal 
wound leads to increased risk for infection and wound 
dehiscence in the post-operative phase.  Insulin infusion 
during the procedure, and 24 hours post procedure, helps 
ensure blood sugar management under 180 mg/dL, 
where experts have determined the point of lowest risk 
for  complications during recovery.  Nurses are pivotal in 
the role of insulin infusion management in the ICU.  
Nurses, physicians, and other supportive personnel need 
to work together to promote the environment that 
excellent glycemic control is necessary in the 
management of diabetic patients before, during, and after 
CABG and cardiac procedures to ensure the best 




The stress of surgery has often been 
explained as a major factor in patients 
experiencing hyperglycemia in the acute 
hospital setting.  Quantifying the effects 
of poor glycemic control in hospitalized 
patients is often difficult.  Numerous 
studies have been conducted to focus on 
better blood sugar management for 
medically hospitalized patients, but far 
fewer have been conducted to show the 
poor outcomes from hyperglycemia with 
surgical patients.  In many patients, the 
stress of surgery can cause high blood 
sugars due to increased stress hormones 
such as epinephrine and norepinephrine. 
Growth hormone, glucagon, 
gluconeogenesis, and cortisol levels also 
increase under stressful conditions 
contributing to a worsening 
hyperglycemic state. Another problem 
that arises is a decrease in insulin levels 
due to reduced secretion from the 
pancreas and increased insulin 
resistance at the receptor sites on muscle 
cells (Raju, Torjman, & Goldberg, 2009, 
p. 1283). 
 
A study conducted by the Department of 
Endocrinology at Boston University 
Medical Center was able to surmise that 
up to 80% of patients that had cardiac 
surgery developed high blood sugars 
over 200 mg/dL at some point in the 
surgical process.  This suggests 
prolonged length of stay and increased 
hospital costs (Alexanian, McDonnell, & 
Akhtar, 2011, p. 1).   
 
Another study conducted by the 
Department of Cardiothoracic Surgery at 
The Boston Medical Center states that up 
to 40 % of patients having a coronary 
artery bypass graft procedure (CABG) 
already have a diagnosis of either 
diabetes or metabolic syndrome.  These 
patients are at very high risk of needing 
repeat procedures and hospitalizations 
due to poor healing and increased 
infection of the incisions to the chest and 
to the sites of the graft vessels (Lazer, 
2012, p. 1).   
 
 
The goal of this poster presentation is to 
demonstrate how excellent glycemic 
control before, during, and after 
coronary artery bypass graft procedure 
can dramatically decrease mortality and 





A 72 year old male patient was admitted to 
the hospital presenting with sharp sub-
sternal pain and pressure to the left upper 
chest rated a “10” out of 10.  Patient 
complained of chest pain even at rest 
which was relieved by a nitroglycerin 
infusion.  Patient had established coronary 
artery disease as evidenced by five prior 
stent placements, with the last stent 
placement being in 2010.  The patient also 
presented to the Emergency Room with a 
blood glucose level over 600 mg/dL and 
because of his complaints of chest pain, 
was transferred to a neighboring hospital 
facility to have a cardiac catheterization 
procedure.  Past medical history included:  
uncontrolled type 2 diabetes with an A1c 
value of 10.0 %, coronary artery disease, 
hyperlipidemia, hypertension, 
gastroesophageal reflux disease (GERD), 
and osteoarthritis.  Cardiac catheterization 
procedure was performed and 
recommendation for him to have open 
heart surgery due to three vessels being 
90-100% occluded was given.  Patient 
underwent three vessel coronary artery 
bypass graft procedure (CABG) the 
following week and was discharged to an 
extended care facility (ECF) for 
rehabilitation another week later after 
having difficulty managing blood sugars 
under 225 mg/dL.  Other postoperative 
course in the hospital was unremarkable 
and uneventful.   
 
One week later, the patient was re-
admitted to the hospital with blood sugars 
in the 400 mg/dL range and complaints of 
increased soreness to the chest in the 
incision area.  The sternal wound showed 
signs of dehiscence to the point of 
stretching the sternal wires.  After two 
days of antibiotic therapy, patient 
underwent mediastinal exploration with 
removal of sternal wires and sternal plate, 
and an advanced pectoralis flap surgery 
was performed.  Patient returned to the 
ECF for rehabilitation after being medically 
stabilized.  Two months later, the patient 
was re-admitted to the hospital for signs 
and symptoms of wound infection.  After 
antibiotic treatment, the patient returned 
to the ECF for the remainder of 
rehabilitation. 
 
Unfortunately, this is a true case study and 
occurs in many facilities across the 
country.  What could have been done 
differently to facilitate a better outcome? 
 
 Otterbein University, Westerville, Ohio  
Summary of the healing process. 
Intermediate phase of the repair reaction. 
(A) As a new extracellular matrix is deposited 
at the wound site, the initial fibrin clot is 
lysed by a combination of extracellular 
proteolytic enzymes and phagocytosis. 
(B) Concurrent with fibrin removal, there is 
deposition of a temporary matrix formed by 
proteoglycans, glycoproteins, and type III 
collagen.   
(C) Final phase of the repair reaction. 
Eventually the temporary matrix is removed 
by a combination of extracellular  
 and intracellular digestion, and the 
definitive matrix, rich in type I collagen, is 
deposited. 
 
Reproduced with permission from: Rubin E, 
Farber JL. Pathology, 3rd Edition. 
Philadelphia: Lippincott Williams & Wilkins, 
1999. Copyright © 1999 Lippincott Williams 
& Wilkins. 
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Implications for Nursing 
 
Nurses play a vital role in the management of the insulin infusion in the ICU setting.  
According to the hospital’s algorithm, titration of the infusion rate is managed by 
hourly blood sugar measurements.  Nurses must be knowledgeable in the management 
of diabetic patients as often, their needs for insulin change in the postoperative setting.  
Staff education regarding management of the insulin infusion, parameters for expected 
blood sugar values, and when to notify the physician should be completed.  Patient 
education must be performed at every juncture within the surgery process.  
Instruction is given during pre-admission testing as to whether to give or hold home 
oral hyperglycemics as well as how much of the insulin dose to be given 24 hours prior 
to surgery.  Sternal precautions need to be taught and reinforced throughout the 
hospital stay.  Lastly, prior to discharge, the bedside nurse gives instruction regarding 
home medications to be taken , dietary regimen, and frequency of blood sugar 





In normal heart function, the main energy 
source for the non-ischemic myocardium is free 
fatty acids.  During ischemic events, free fatty 
acids can no longer be used as the 
myocardium’s energy source, and so, glucose is 
chosen.  In diabetic patients who are already 
insulin resistant, impaired glucose metabolism 
leads to increased serum glucose levels.  
Increased levels of free fatty acids due to 
ischemia increases oxygen use, creates insulin 
resistance, decreases pumping ability, increases 
risk of lethal arrhythmias, increases risk for 
thrombus and plaque rupture, and impairs 
function of platelets. An increased blood sugar 
over 250 mg/dL can place a patient at a 10-fold 
increase of complications after surgery  (Lazer, 
2012, p. 1-2).   
  
Hyperglycemia impairs wound healing by 
hindering collagen production leading to 
decreased strength in the surgical wound 
placing the patient at high risk for dehiscence.  
Infection risk is increased due to impairment of 
leukocyte phagocytosis and chemotaxis (Lynn 
Gieger, 2009, p. 12).  During surgery, insulin 
requirements increase due to increased insulin 
resistance caused by hypothermia, increased 
glucose from cardioplegic solution, and 
inotropic support.  
 
 All of these factors combined place the diabetic 
patient at extreme risk of wound dehiscence, 
infected incision,  and sepsis thereby increasing 
the risk of mortality (Lazer, 2012, p. 4).  Medical 
staff must be vigilant in excellent blood sugar 














1—Principal mechanisms responsible for endothelial dysfunction in diabetes. NO is the principal anti-atherosclerotic 
endothelium-derived mediator. It is formed from L-arginine by eNOS, being tetrahydrobiopterin (BH4), a crucial cofactor for the 
reaction. Endothelial dysfunction is defined by the presence of a reduced NO bioavailability. In the presence of diabetes, 
characterized by the existence of insulin resistance and hyperglycemia, endothelial dysfunction is due to both reduced production 
(increased circulating levels of the eNOS endogenous inhibitor asymmetric dimethylarginine [ADMA], decreased cellular levels of 
BH4 and decreased eNOS activation) and to an increased breakdown of NO by ROS. AGEs, advanced aging end products; FFA, 
free fatty acids (Versari, Daghini, Virdis,Ghiadoni, & Taddei, 2009 pS314. 
Role of Insulin During CABG Procedure 
 
 
IV insulin during CABG surgery and the post-operative period is the preferred choice 
of correction of increased blood sugars due to its short half-life and rapid action.  IV 
insulin should be maintained for at least 24 hours after surgery to ensure the best 
blood sugar management (Alexanian, McDonnell, & Akhtar, 2011, p. 2).   Studies show 
that insulin encourages myocardial glucose uptake, inhibits release of free fatty acids, 
and reverses the harmful effects of oxidative stress caused by hyperglycemia on the 
myocardium.  Insulin has also been shown to better preserve the neutrophil’s 
phagocytic function  which can aid in reduction of wound infections often seen in 
diabetic CABG patients (Lazer, 2012, p. 2) Metformin is recommended to be 
discontinued for 48 hours prior to surgery and not restarted until kidney function is 
optimal.  Metformin can increase the risk for lactic acidosis in the intraoperative period 
(Raju, Torjman, & Goldberg, 2009, p. 1283).  IV insulin can be used in lieu of 
metformin throughout the hospital stay.   The guidelines to postpone CABG surgery 
due to poor blood sugar control has not been established at this time.  Surgeons and 
medical staff must consider several factors including:  urgency of surgery, overall 
health of the patient, and metabolic status to ensure the best possible outcome  for the 
diabetic cardiac patient (Alexanian, McDonnell, & Akhtar, 2011, p. 2).  The blood sugar 
goal to best ensure optimal healing is under 180 mg/dL and most easily attained by IV 
insulin infusion (Lazar, et al., 2009, p. 3).  
Other Factors Causing Dysfunction in Blood  
Sugar Management 
 
Cardioplegic solution often used to paralyze the heart in order to perform CABG 
surgery contains amino acids, MSG (Monosodium glutamate), MSA (monosodium 
aspartate), CPD (Citrate Phosphate Dextrose Solution), Dextrose, Thromethamine, and 
KCL.  The dextrose present in cardioplegic solution serves as a substrate for glycolysis 
to supply the myocardium during the bypass procedure, however, the additional 
glucose load leads to increased hyperglycemia and insulin resistance in the already 
compromised diabetic heart (Minasian, Galagudza, Dmitriev, Kurapeev, & and Vlascov, 
2013, p. 3). 
